List of Fluorescein Sodium And Benoxinate Hydrochloride drug patents

Fluorescein Sodium And Benoxinate Hydrochloride is owned by Bausch Lomb Ireland.

Fluorescein Sodium And Benoxinate Hydrochloride contains Benoxinate Hydrochloride; Fluorescein Sodium.

Fluorescein Sodium And Benoxinate Hydrochloride has a total of 3 drug patents out of which 0 drug patents have expired.

Fluorescein Sodium And Benoxinate Hydrochloride was authorised for market use on 09 March, 2020.

Fluorescein Sodium And Benoxinate Hydrochloride is available in solution/drops;ophthalmic dosage forms.

Fluorescein Sodium And Benoxinate Hydrochloride can be used as ocular examination, intraocular pressure measurement, or removal of foreign bodies or sutures, in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic, procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic..

The generics of Fluorescein Sodium And Benoxinate Hydrochloride are possible to be released after 15 November, 2037.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10842872 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(14 years from now)

US10632197 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(14 years from now)

US10293047 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(14 years from now)

Drugs and Companies using BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM ingredient

Market Authorisation Date: 09 March, 2020

Treatment: Procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic.; Ocular examination, intraocular pressure measurement, or removal of foreign bodies or sutures, in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in